Friday, April 10, 2026

Synergistic Antitumor Effects of 2'-Nitroflavone (2'NF) & Safingol in Breast Cancer

The International Cancer and Precision Oncology Conference (ICPOC 2026) continues to showcase impactful scientific contributions through its YouTube presentation series.

This featured presentation explores innovative therapeutic strategies in breast cancer treatment, focusing on the synergistic effects of 2'-Nitroflavone (2'NF) and Safingol.


👩🔬 Speaker Details

Speaker: Viviana C. Blank
🏛️ University of Buenos Aires, Argentina


🔬
Presentation Highlights

This research investigates the molecular mechanisms driving enhanced antitumor activity through combination therapy:

  • SPHK1 signaling pathway modulation
  • MAPK pathway activation
  • Induction of endoplasmic reticulum (ER) stress
  • Targeting oncogenic signaling networks
  • Improving therapeutic efficacy in breast cancer models

The study demonstrates how combining these compounds may offer a promising direction for advanced cancer treatment strategies.


▶️ Watch the Full Presentation

https://youtu.be/iVK4ZF0u1Qs?list=PLck-LAAvob8cSr201NPANCi7lhMM6Z8wn


🌍 About ICPOC 2026

Join global researchers, clinicians, and oncology experts at ICPOC 2026 to explore the latest advancements in cancer science and precision oncology.

📅 November 23–25, 2026
📍 Singapore & Online

🌐 https://cancer.miconferences.com/
📩 info@mathewsconference.com
💬 +1 (424) 377 0967


🔖 Hashtags

#ICPOC2026 #CancerResearch #BreastCancer #Oncology #CancerTherapy #PrecisionOncology #MolecularBiology #TargetedTherapy #CancerScience #MedicalResearch #ClinicalResearch #CancerInnovation #OncologyConference #BiomedicalResearch #TranslationalResearch

Synergistic Antitumor Effects of 2'-Nitroflavone (2'NF) & Safingol in Breast Cancer

The International Cancer and Precision Oncology Conference (ICPOC 2026) continues to showcase impactful scientific contributions through it...